Minimal clinically important difference of voice handicap index‐10 in vocal fold paralysis

Young, VyVy N.; Jeong, Kwonho; Rothenberger, Scott D.; Gillespie, Amanda I.; Smith, Libby J.; Gartner‐Schmidt, Jackie; Rosen, Clark A.

doi:10.1002/lary.27001

Cited by 52 publications

(49 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with vocal fold paralysis, an improvement of 4 points on the VHI-10 scale has been suggested to be the minimal clinically important difference that results in a perceivable voice change. 16 Misono et al also reported on patients with a variety of vocal fold disorders and found that the minimal important difference on the VHI-10 scale was 6 points. 17 Currently, these are the only reference values to indicate a clinically significant voice improvement that is notable by patients.…”

Section: Discussionmentioning

confidence: 98%

“…Even at the point of lowest/best VHI‐10 score, the patients in the ML group still reported better voice outcomes. In patients with vocal fold paralysis, an improvement of 4 points on the VHI‐10 scale has been suggested to be the minimal clinically important difference that results in a perceivable voice change . Misono et al also reported on patients with a variety of vocal fold disorders and found that the minimal important difference on the VHI‐10 scale was 6 points .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

2018

View full text Add to dashboard Cite

Objective To compare voice outcomes of autogenous fat injection versus medialization laryngoplasty in patients with glottic insufficiency due to vocal fold paresis or atrophy. Methods A retrospective review was performed from 2009 to 2017 of all patients who underwent lipoinjection or medialization laryngoplasty (ML) for glottic insufficiency. Charts were reviewed for demographic information, preoperative diagnosis, surgical intervention, Voice Handicap Index‐10 (VHI‐10) and Glottal Function Index (GFI) scores, follow‐up time (minimum 3 months), and concomitant voice therapy. Results Eighty‐three patients were initially identified and limited to 28 based on the inclusion/exclusion criteria. Thirty‐five procedures were performed with a total of 15 fat injections and 20 MLs. The mean age was 60.7 years in the lipoinjection group and 55.6 years in the ML group. There was no significant difference in pretreatment VHI‐10 scores between the two groups. Using the lowest recorded voice scores during the follow‐up period, both groups had a significant decrease (P < 0.05) compared to preoperative scores (VHI‐10: fat decreased from 27.8 to 14.2, ML decreased from 30.5 to 9.1; GFI: fat decreased from 13.7 to 5.27, ML decreased from 13.6 to 4.6). When evaluating the entire follow‐up period (median 19 months in fat group, 16.3 months in ML), only the ML group maintained a significant improvement in VHI‐10 (median delta 14.5) and GFI (median delta 7) compared to preoperative scores. Conclusion Although both autogenous fat injection and ML result in improved voice scores in the short term, the effect of fat injection appears to be limited, as evidenced by worsening VHI‐10 and GFI scores over time. Level of Evidence 4 Laryngoscope, 129:1164–1168, 2019

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Discussionmentioning

confidence: 99%

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

2018

View full text Add to dashboard Cite

show abstract

“…Nevertheless, our result is qualitatively consistent with what has been previously found for other validated patient‐reported outcome measures. Previous studies of other validated (otolaryngic and non‐otolaryngic) patient‐reported outcome measures have reported sensitivities in the range of 50‐60% for MCID estimates in detecting patients reporting noticeably improved outcomes …”

Section: Discussionmentioning

confidence: 99%

Minimal clinically important difference for the 22‐item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis

Phillips

Hoehle

Caradonna

et al. 2018

Clinical Otolaryngology

102

View full text Add to dashboard Cite

show abstract

“…The total score is used to indicate the severity of the voice disorders for the patient. Higher scores indicate that a voice problem has a more severe handicapping effect on the individual’s life than a lower score [ 12 – 14 ]. Maximum phonation time (MPT) is also a clinical tool for assessing phonatory mechanics.…”

Section: Methodsmentioning

confidence: 99%

Minimally invasive injection laryngoplasty in the management of unilateral vocal cord paralysis after video-assisted mediastinal lymph adenectomy.

Kara

Batıoğlu-Karaaltın

Erşen

et al. 2018

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

IntroductionVideo-assisted mediastinal lymphadenectomy (VAMLA) is a valuable tool for invasive staging of the mediastinum. Unilateral vocal cord paralysis (UVCP) may occur in patients following VAMLA and may result in secretion retention within the lungs, atelectasis and associated infectious situations such as pneumonia. Minimally invasive injection laryngoplasty (ILP) is the treatment of choice in UVCP.AimTo evaluate the efficacy and success of acute minimally invasive injection laryngoplasty for patients with UVCP following VAMLA.Material and methodsPatients with the symptom of dysphonia following VAMLA were reviewed. All of the patients had UVCP according to the video laryngoscopy examination and had symptoms of aspiration and ineffective coughing. The Voice Handicap Index (VHI) questionnaire and maximum phonation time (MPT) were measured. Minimally invasive ILP was performed under general anesthesia with 1 cm of hyaluronic acid.ResultsThere were 525 consecutive non-small cell lung cancer (NSCLC) patients who underwent VAMLA. Five (0.95%) of the patients had UVCP and were suffering from aspiration during oral intake and ineffective coughing reflex. Maximum phonation time (MFT) was measured before and after ILP, and the results were 7.1 ±1.6 and 11.1 ±2.3 s, respectively (p < 001). The Voice Handicap Index-10 (VHI-10) score was 30.4 ±4.7 and 13.4 ±3.5 (p < 0.01), respectively. Patients underwent surgical lung resection. There was no morbidity or mortality.ConclusionsUnilateral vocal cord paralysis may occur as a complication of VAMLA. ILP may be an active tool for treating UVCP before anatomical lung resection to avoid potential morbidities. Successful management of this complication with multidisciplinary team work may encourage the use of VAMLA more frequently.

show abstract

Minimal clinically important difference of voice handicap index‐10 in vocal fold paralysis

Abstract: 4. Laryngoscope, 128:1419-1424, 2018.

Cited by 52 publications

References 45 publications

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency

Minimal clinically important difference for the 22‐item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis

Minimally invasive injection laryngoplasty in the management of unilateral vocal cord paralysis after video-assisted mediastinal lymph adenectomy.

Contact Info

Product

Resources

About